SMC accepts clobetasol propionate 0.05% shampoo (Etrivex) for moderate scalp psoriasis (resubmission)

Source: Scottish Medicines Consortium (SMC)

Date published: 11/08/2008 16:46

Summary
by: Nicola Pocock

The Scottish Medicines Consortium (SMC) has accepted clobetasol propionate 0.05% shampoo (Etrivex®) for use within NHS Scotland for the topical treatment of moderate scalp psoriasis in adults.  The drug advice notes that a comparison of clobetasol propionate 0.05% shampoo to another clobetasol formulation demonstrated non-inferiority and costs are similar; please see the link below for further details.

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.